glp-1 obesity drug news today october 16 2025 Exploring the Side Effects of Receptor Agonist: To Ensure Its Optimal Positioning ISPOR 2025: Exploring reasons for
Description
Hypertension 3012671273

Diabetes 63(12):41864196 Baggio LL, Drucker DJ (2014) Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
14, 2023 Semaglutide and Cardiovascular Outcomes in Patients Without Diabetes A Michael Lincoff, et

According to the World Obesity Federations 2025 Atlas, the number of adults living with obesity is expected to more than double from 524 million in 2010 to 1.13 billion by 2030

It is a chronic disease, says Iman Saleh, MD, an obstetrician-gynecologist and the director of obesity medicine at Northwell Healths South Shore University Hospital in Bay Shore, New York

They advocate routine preoperative gastric ultrasonography and recommend anesthetic management strategies, including airway protection, rapid sequence intubation, and general anesthesia